Cytoprotection by the NO-donor SNAP against ischemia/reoxygenation injury in mouse embryonic stem cell-derived cardiomyocytes

Molecular Biotechnology

Volumn 56, Issue 3, 2014, Pages 258-264

  Gorbe A ^a,h   Varga, Z V ^a,g   Paloczi J ^a   Rungarunlert, S ^b,c,k   Klincumhom, N ^b,e,l   Pirity, M K ^e,i   Madonna, R ^f,j   Eschenhagen, T ^d   Dinnyes A ^c,e   Csont, T ^a,h   Ferdinandy, P ^g,h  

^a UNIVERSITY OF SZEGED   (Hungary)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c SZENT ISTVÁN UNIVERSITY   (Hungary)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e BIOTALENTUM LTD   (Hungary)

^f TEXAS HEART INSTITUTE   (United States)

^g SEMMELWEIS UNIVERSITY   (Hungary)

^h PHARMAHUNGARY GROUP   (Hungary)

ⁱ INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^j UNIVERSITY OF CHIETI   (Italy)

^k MAHIDOL UNIVERSITY   (Thailand)

^l MAHIDOL UNIVERSITY   (Thailand)

more..

Author keywords

Cardioprotection; Ischemia reoxygenation; Nitric oxide; Signal transduction; Stem cell

Indexed keywords

CARDIOPROTECTION; CONCENTRATION-DEPENDENT MANNERS; CYTOPROTECTIVE EFFECTS; CYTOPROTECTIVE MOLECULES; EMBRYONIC STEM CELLS; ISCHEMIA/REOXYGENATION; ISCHEMIA/REPERFUSION; NATRIURETIC PEPTIDES;

AMINO ACIDS; CELL DEATH; MAMMALS; MOLECULES; NITRIC OXIDE; SIGNAL TRANSDUCTION; STEM CELLS;

CHEMICAL COMPOUNDS;

BRAIN NATRIURETIC PEPTIDE; CYCLIC GMP DEPENDENT PROTEIN KINASE; GLIBENCLAMIDE; GUANYLATE CYCLASE; GUANYLATE CYCLASE ACTIVATOR; N NITRO LEVO ARGININE; NITRIC OXIDE SYNTHASE; PENICILLAMINE DERIVATIVE; PROPIDIUM IODIDE; S NITRO N ACETYL DEXTRO LEVO PENICILLAMINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CULTURE; CELL DEATH; CELL PROTECTION; CELL SCREENING; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG SCREENING; EMBRYONIC STEM CELL; HEART MUSCLE CELL; HEART PROTECTION; MOUSE; NONHUMAN; REOXYGENATION; REOXYGENATION INJURY; REPERFUSION INJURY; SIGNAL TRANSDUCTION;

ANIMALS; CELL DEATH; CELL SURVIVAL; CELLS, CULTURED; EMBRYONIC STEM CELLS; ISCHEMIA; MICE; MICE, INBRED C57BL; MYOCYTES, CARDIAC; NITRIC OXIDE; S-NITROSO-N-ACETYLPENICILLAMINE;

EID: 84896715484     PISSN: 10736085     EISSN: 15590305     Source Type: Journal    
DOI: 10.1007/s12033-013-9704-2     Document Type: Article

References (31)

1. Hansen, A., Eder, A., Bonstrup, M., Flato, M., Mewe, M., Schaaf, S., et al. (2010). Development of a drug screening platform based on engineered heart tissue. Circulation Research, 107(1), 35-44.
2. Woodcock, E. A., & Matkovich, S. J. (2005). Cardiomyocytes structure, function and associated pathologies. International Journal of Biochemistry & Cell Biology, 37(9), 1746-1751.
3. Xu, C., Police, S., Rao, N., & Carpenter, M. K. (2002). Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells. Circulation Research, 91(6), 501-508.
4. Harding, S. E., Ali, N. N., Brito-Martins, M., & Gorelik, J. (2007). The human embryonic stem cell-derived cardiomyocyte as a pharmacological model. Pharmacology & Therapeutics, 113(2), 341-353.
5. Liang, H., Matzkies, M., Schunkert, H., Tang, M., Bonnemeier, H., Hescheler, J., et al. (2010). Human and murine embryonic stem cell-derived cardiomyocytes serve together as a valuable model for drug safety screening. Cellular Physiology and Biochemistry, 25(4-5), 459-466.
6. Zimmermann, W. H., & Eschenhagen, T. (2007). Embryonic stem cells for cardiac muscle engineering. Trends in Cardiovascular Medicine, 17(4), 134-140.
7. Wollert, K. C. (2005). Clinical applications of stem cells for the heart. Circulation Research, 96(2), 151-163.
8. Qiao, H., Zhang, H., Zheng, Y., Ponde, D. E., Shen, D., Gao, F., et al. (2009). Embryonic stem cell grafting in normal and infarcted myocardium: Serial assessment with MR imaging and PET dual detection. Radiology, 250(3), 821-829.
9. Suzuki, K. (2004). Dynamics and mediators of acute graft attrition after myoblast transplantation to the heart. FASEB Journal, 18(10), 1153-1155.
10. Gorbe, A. (2010). Role of cGMP-PKG signaling in the protection of neonatal rat cardiac myocytes subjected to simulated ischemia/reoxygenation. Basic Research in Cardiology, 105(5), 643-650.
11. Bell, R. M. (2001). The contribution of endothelial nitric oxide synthase to early ischaemic preconditioning: The lowering of the preconditioning threshold. An investigation in eNOS knockout mice. Cardiovascular Research, 52(2), 274-280.
12. Csont, T. (1999). Direct myocardial anti-ischaemic effect of GTN in both nitrate-tolerant and nontolerant rats: A cyclic GMP-independent activation of KATP. British Journal of Pharmacology, 128(7), 1427-1434.
13. Belteki, G. (2003). Site-specific cassette exchange and germline transmission with mouse ES cells expressing phiC31 integrase. Nature Biotechnology, 21(3), 321-324.
14. Mummery, C. L. (2007). Differentiation of human embryonic stem cells to cardiomyocytes by coculture with endoderm in serum-free medium. Current Protocols in Stem Cell Biology. doi: 10.1002/9780470151808.sc01f02s2.
15. Li, X. (2004). Role of connexin 43 in ischemic preconditioning does not involve intercellular communication through gap junctions. Journal of Molecular and Cellular Cardiology, 36(1), 161-163.
16. D'Souza, S. P. (2003). B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening. American Journal of Physiology, 284(5), H1592-H1600.
17. Milkiewicz, M. (2006). Nitric oxide and p38 MAP kinase mediate shear stress-dependent inhibition of MMP-2 production in microvascular endothelial cells. Journal of Cellular Physiology, 208(1), 229-237.
18. Ferdinandy, P. (1995). KATP channel modulation in working rat hearts with coronary occlusion: Effects of cromakalim, cicletanine, and glibenclamide. Cardiovascular Research, 30(5), 781-787.
19. Walsh, K. B., Rich, T. C., & Coffman, Z. J. (2009). Development of a high-throughput assay for monitoring cAMP levels in cardiac ventricular myocytes. Journal of Cardiovascular Pharmacology, 53(3), 223-230.
20. Ozsvari, B., Puskas, L. G., Nagy, L. I., Kanizsai, I., Gyuris, M., Madacsi, R., et al. (2010). A cell-microelectronic sensing technique for the screening of cytoprotective compounds. International Journal of Molecular Medicine, 25(4), 525-530.
21. Nakano, A., Liu, G. S., Heusch, G., Downey, J. M., & Cohen, M. V. (2000). Exogenous nitric oxide can trigger a preconditioned state through a free radical mechanism, but endogenous nitric oxide is not a trigger of classical ischemic preconditioning. Journal of Molecular and Cellular Cardiology, 32(7), 1159-1167.
22. Takano, H., Tang, X. L., Qiu, Y., Guo, Y., French, B. A., & Bolli, R. (1998). Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism. Circulation Research, 83(1), 73-84.
23. Maejima, Y., Adachi, S., Ito, H., Nobori, K., Tamamori-Adachi, M., & Isobe, M. (2003). Nitric oxide inhibits ischemia/reperfusion-induced myocardial apoptosis by modulating cyclin A-associated kinase activity. Cardiovascular Research, 59(2), 308-320.
24. Kanno, S. (2004). Nitric oxide facilitates cardiomyogenesis in mouse embryonic stem cells. Proceedings of the National Academy of Sciences of the United States of America, 101(33), 12277-12281.
25. Ferdinandy, P. (2003). Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. British Journal of Pharmacology, 138(4), 532-543.
26. Krumenacker, J. S. (2006). Differential expression of genes involved in cGMP-dependent nitric oxide signaling in murine embryonic stem (ES) cells and ES cell-derived cardiomyocytes. Nitric Oxide, 14(1), 1-11.
27. Abdelalim, E. M., & Tooyama, I. (2009). BNP signaling is crucial for embryonic stem cell proliferation. PLoS One, 4(4), e5341.
28. Mobley, S. (2010). PKG and PKC are down-regulated during cardiomyocyte differentiation from embryonic stem cells: Manipulation of these pathways enhances cardiomyocyte production. Stem Cells International. doi: 10.4061/2010/701212.
29. Xu, Z. (2004). Exogenous nitric oxide generates ROS and induces cardioprotection: Involvement of PKG, mitochondrial KATP channels, and ERK. American Journal of Physiology, 286(4), H1433-H1440.
30. Gryshchenko, O. (1999). Role of ATP-dependent K(+) channels in the electrical excitability of early embryonic stem cell-derived cardiomyocytes. Journal of Cell Science, 112(17), 2903-2912.
31. Baharvand, H., Hajheidari, M., Zonouzi, R., Ashtiani, S. K., Hosseinkhani, S., & Salekdeh, G. H. (2006). Comparative proteomic analysis of mouse embryonic stem cells and neonatal-derived cardiomyocytes. Biochemical and Biophysical Research Communications, 349(3), 1041-1049.